These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 16831981
21. Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP. Squire I, Quinn P, Narayan H, Khan S, Dhillon O, Ng K, Kelly D, Davies J, Ng L. Heart; 2010 Jun; 96(11):831-7. PubMed ID: 20478862 [Abstract] [Full Text] [Related]
22. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting. van der Harst P, Voors AA, Volbeda M, Buikema H, van Veldhuisen DJ, van Gilst WH. Am J Cardiol; 2006 Jun 15; 97(12):1697-701. PubMed ID: 16765116 [Abstract] [Full Text] [Related]
23. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H. J Am Coll Cardiol; 2009 Aug 11; 54(7):601-8. PubMed ID: 19660689 [Abstract] [Full Text] [Related]
24. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, Münzel T, Cambien F, Tiret L, Blankenberg S, AtheroGene Investigators. Eur Heart J; 2005 Feb 11; 26(3):241-9. PubMed ID: 15618051 [Abstract] [Full Text] [Related]
27. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients. Shadman R, Allison MA, Criqui MH. J Am Coll Cardiol; 2007 Jun 05; 49(22):2172-81. PubMed ID: 17543637 [Abstract] [Full Text] [Related]
28. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW. J Am Coll Cardiol; 2008 Mar 25; 51(12):1188-95. PubMed ID: 18355657 [Abstract] [Full Text] [Related]
29. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. Perna ER, Macin SM, Cimbaro Canella JP, Szyszko A, Franciosi V, Vargas Morales W, Bayol AP, Kriskovich JO, Medina F, Gonzalez Arjol B, Brizuela M. J Heart Lung Transplant; 2006 Oct 25; 25(10):1230-40. PubMed ID: 17045936 [Abstract] [Full Text] [Related]
30. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Pradhan AD, Shrivastava S, Cook NR, Rifai N, Creager MA, Ridker PM. Circulation; 2008 Feb 12; 117(6):823-31. PubMed ID: 18227386 [Abstract] [Full Text] [Related]
31. Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation. Sanchis J, Bosch X, Bodí V, Bellera N, Núñez J, Benito B, Ordóñez J, Consuegra L, Heras M, Llècer A. Heart; 2008 Mar 12; 94(3):311-5. PubMed ID: 17639094 [Abstract] [Full Text] [Related]
32. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy. van Diepen S, Newby LK, Lopes RD, Stebbins A, Hasselblad V, James S, Roe MT, Ezekowitz JA, Moliterno DJ, Neumann FJ, Reist C, Mahaffey KW, Hochman JS, Hamm CW, Armstrong PW, Granger CB, Theroux P, APEX AMI Investigators. Int J Cardiol; 2013 Oct 03; 168(3):2127-33. PubMed ID: 23394896 [Abstract] [Full Text] [Related]
33. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Circulation; 2007 Apr 24; 115(16):2119-27. PubMed ID: 17404162 [Abstract] [Full Text] [Related]
36. Multiple biomarkers for the prediction of first major cardiovascular events and death. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS. N Engl J Med; 2006 Dec 21; 355(25):2631-9. PubMed ID: 17182988 [Abstract] [Full Text] [Related]
37. N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis. Wolber T, Maeder M, Rickli H, Riesen W, Binggeli C, Duru F, Ammann P. Eur J Clin Invest; 2007 Jan 21; 37(1):18-25. PubMed ID: 17181563 [Abstract] [Full Text] [Related]
38. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes. O'Malley T, Ludlam CA, Riemermsa RA, Fox KA. Eur Heart J; 2001 Jul 21; 22(14):1226-34. PubMed ID: 11440495 [Abstract] [Full Text] [Related]
40. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. Bayes-Genis A, Pascual-Figal D, Fabregat J, Domingo M, Planas F, Casas T, Ordoñez-Llanos J, Valdes M, Cinca J. Int J Cardiol; 2007 Sep 03; 120(3):338-43. PubMed ID: 17174423 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]